Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yılmaz T, Gümüş E, Barış S, Kuşkonmaz B, Ozgur TT, Bali P, Santisteban I, Orhan D, Yüce A, Cetinkaya D, Boztug K, Hershfield M, Sanal O, Tezcan İ. Cagdas D, et al. Among authors: cetinkaya d, gur cetinkaya p. J Clin Immunol. 2018 May;38(4):484-493. doi: 10.1007/s10875-018-0496-9. Epub 2018 May 9. J Clin Immunol. 2018. PMID: 29744787
Subcutaneous venom immunotherapy in children: Efficacy and safety.
Gür Çetinkaya P, Esenboğa S, Uysal Soyer Ö, Tuncer A, Şekerel BE, Şahiner ÜM. Gür Çetinkaya P, et al. Ann Allergy Asthma Immunol. 2018 Apr;120(4):424-428. doi: 10.1016/j.anai.2018.01.015. Ann Allergy Asthma Immunol. 2018. PMID: 29625665
Safety and efficacy of rapid drug desensitization in children.
Esenboga S, Akarsu A, Ocak M, Gur Cetinkaya P, Sahiner UM, Sekerel BE, Soyer O. Esenboga S, et al. Among authors: gur cetinkaya p. Pediatr Allergy Immunol. 2022 Mar;33(3):e13759. doi: 10.1111/pai.13759. Pediatr Allergy Immunol. 2022. PMID: 35338724
Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss.
Gür-Çetinkaya P, Çağdaş-Ayvaz DN, Öksüz AB, Ertoy A, Hayran U, Özkan F, Erol M, Tezcan İ. Gür-Çetinkaya P, et al. Turk J Pediatr. 2018;60(3):270-276. doi: 10.24953/turkjped.2018.03.006. Turk J Pediatr. 2018. PMID: 30511539 Free article.
Gur-Cetinkaya P, Cagdas-Ayvaz DN, Oksuz AB, Ertoy A, Hayran U, Ozkan F, Erol M, Tezcan I. ...Infections were more frequent under intravenous than subcutaneous route (p=0.004). We observed an increase in immunoglobulin levels under subcutaneous route ( …
Gur-Cetinkaya P, Cagdas-Ayvaz DN, Oksuz AB, Ertoy A, Hayran U, Ozkan F, Erol M, Tezcan I. ...Infections were more frequ …
15 results